Impact of PSA implementation and combined radiation and hormonal therapy (RT + HT) on outcome of prostate cancer patients

European Journal of Cancer

Volumn 45, Issue 16, 2009, Pages 2804-2809

  Bellmunt, Joaquim ^a   Macià, Francesc ^b,c   Malmusi, Davide ^b,c   Llorente, José A ^a   Carles, Joan ^a   Lloreta, Josep ^a   Foro, Palmira ^e   Gelabert, Antoni ^a   Albanell, Joan ^a   Castells, Xavier ^b,d  

^a HOSPITAL DEL MAR   (Spain)

^b INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^d Del Mar University   (Spain)

^e HOSPITAL DE L ESPERANÇA   (Spain)

Author keywords

Mortality; Mortality trends; Prostate specific antigen; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSTATE CANCER; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC AGENTS, HORMONAL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; HUMANS; INCIDENCE; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SPAIN; TREATMENT OUTCOME;

EID: 70350013581     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.06.019     Document Type: Article

References (27)

1. McDavid K., Lee J., Fulton J.P., Tonita J., and Thompson T.D. Prostate cancer incidence and mortality rates and trends in the United States and Canada. Public Health Rep 119 (2004) 174-186
2. Quinn M., and Babb P. Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons. BJU Int 90 (2002) 162-173
3. Quaglia A., Parodi S., Grosclaude P., Martinez-Garcia C., Coebergh J.W., and Vercelli M. Differences in the epidemic rise and decrease of prostate cancer among geographical areas in Southern Europe. An analysis of differential trends in incidence and mortality in France, Italy and Spain. Eur J Cancer 39 (2003) 654-665
4. Kvåle R., Auvinen A., Adami H.O., et al. Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries. J Natl Cancer Inst 19 (2007) 1881-1887
5. Vercelli M., Quaglia A., Marani E., and Parodi S. Prostate cancer incidence and mortality trends among elderly and adult Europeans. Crit Rev Oncol Hematol 35 (2000) 133-144
6. Bouchardy C., Fioretta G., Rapiti E., et al. Recent trends in prostate cancer mortality show a continuous decrease in several countries. Int J Cancer 123 (2008) 421-429
7. Baade P.D., Coory M.D., and Aitken J.F. International trends in prostate-cancer mortality: the decrease is continuing and spreading. Cancer Causes Control 15 (2004) 237-241
8. Cayuela A., Rodríguez-Domínguez S., Martín V.E., and Candau B.R. Recent changes in prostate cancer mortality in Spain. Trends analysis from 1991 to 2005. [Article in Spanish]. Actas Urol Esp 32 (2008) 184-189
9. Berrino F., De Angelis R., Sant M., et al. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. Lancet Oncol 8 (2007) 773-783
10. Collin S.M., Martin R.M., Metcalfe C., et al. Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study. Lancet Oncol 9 (2008) 445-452
11. Etzioni R., and Feuer E. Studies of prostate-cancer mortality: caution advised. Lancet Oncol 9 (2008) 407-409
12. Jensen OM, Parkin DM, MacLennan R, Muir CS, Skeet RG. Cancer registration: principles and methods. Lyon, France: International Agency for Research on Cancer, 1991. IARC Scientific Publications No. 95.
13. Prostate. American joint committee on cancer: AJCC cancer staging manual. 6th ed. (2002), Springer, New York, NY 309-316
14. D'Amico A.V., Whittington R., Malkowicz S.B., et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280 (1998) 969-974
15. Clèries R., Valls J., Esteban L., et al. WAERS: an application for web-assisted estimation of relative survival. Med Inform Internet Med 32 (2007) 169-175
16. Luján Galán M., Páez Borda A., Chiva Robles V., Santonja Garriga C., Romero Cajigal I., and Berenguer Sánchez A. Epidemiological trends in prostate cancer over the last years. [Article in Spanish]. Arch Esp Urol 57 (2004) 817-825
17. Inghelmann R., Grande E., Francisci S., et al. Regional estimates of prostate cancer burden in Italy. Tumori 93 (2007) 380-386
18. Varenhorst E., Garmo H., Holmberg L., et al. The national prostate cancer register in Sweden 1998-2002: trends in incidence, treatment and survival. Scand J Urol Nephrol 39 (2005) 117-123
19. Potosky A.L., Miller B.A., Albertsen P.C., and Kramer B.S. The role of increasing detection in the rising incidence of prostate cancer. JAMA 273 (1995) 548-552
20. Hemminki K., Rawal R., and Bermejo J.L. Prostate cancer screening, changing age-specific incidence trends and implications on familial risk. Int J Cancer 113 (2005) 312-315
21. Andriole G.L., Grubb III R.L., Buys S.S., et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 360 (2009) 1310-1319
22. Naitoh J., Zeiner R.L., and Dekernion J.B. Diagnosis and treatment of prostate cancer. Am Fam Physician 57 (1998) 1531-1539
23. Etzioni R., Penson D.F., Legler J.M., et al. Overdiagnosis due to prostate-specific antigen screening: lessons from US prostate cancer incidence trends. J Natl Cancer Inst 94 (2002) 981-990
24. Schröder F.H., Hugosson J., Roobol M.J., et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 360 (2009) 1320-1328
25. Cooperberg M.R., Lubeck D.P., Meng M.V., Mehta S.S., and Carroll P.R. The changing face of low-risk prostate cancer: trends in clinical presentation and primary management. J Clin Oncol 22 (2004) 2141-2149
26. Bolla M., Gonzalez D., Warde P., et al. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med 337 (1997) 295-300
27. Bill-Axelson A., Holmberg L., Filén F., et al. Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial. J Natl Cancer Inst 100 (2008) 1144-1154